BioSpace News Archive

Genetown

Voyager Therapeutics Announces Pricing of Public Offering - Jan 05, 2024

Voyager Therapeutics, Inc. announced the pricing of an underwritten public offering of 7,777,778 shares of its common stock at a public offering price of $9.00 per share.

January 4, 2024
·
5 min read
Business

Evolus Announces the Appointment of Nareg Sagherian to Vice President, Head of Global Investor Relations and Corporate Communications

Evolus, Inc. announced that Nareg Sagherian has joined the Company as Vice President, Head of Global Investor Relations and Corporate Communications.

January 4, 2024
·
2 min read
Pharm Country

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Jan 04, 2024

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to one new employee.

January 4, 2024
·
3 min read
Biotech Beach

Avenzo Therapeutics Announces Global License of AVZO-021 (ARTS-021), a Potentially Best-in-Class Clinical Stage CDK2 Inhibitor from Allorion Therapeutics

Avenzo Therapeutics, Inc. today announced that it has entered into an exclusive licensing agreement with Allorion Therapeutics Inc. (Allorion) to develop and commercialize AVZO-021 (formerly ARTS-021), a potentially best-in-class cyclin-dependent kinase 2 (CDK2) selective inhibitor globally (excluding Greater China).

January 4, 2024
·
4 min read